nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1D—meninx—sarcoma	0.101	0.295	CbGeAlD
Naratriptan—HTR1B—dura mater—sarcoma	0.0956	0.28	CbGeAlD
Naratriptan—HTR1D—dura mater—sarcoma	0.0925	0.271	CbGeAlD
Naratriptan—HTR1D—connective tissue—sarcoma	0.00585	0.0172	CbGeAlD
Naratriptan—MAOA—myometrium—sarcoma	0.00539	0.0158	CbGeAlD
Naratriptan—MAOA—embryo—sarcoma	0.00518	0.0152	CbGeAlD
Naratriptan—HTR1A—hematopoietic system—sarcoma	0.00506	0.0149	CbGeAlD
Naratriptan—MAOA—seminal vesicle—sarcoma	0.00487	0.0143	CbGeAlD
Naratriptan—MAOA—hematopoietic system—sarcoma	0.00463	0.0136	CbGeAlD
Naratriptan—MAOA—connective tissue—sarcoma	0.00445	0.0131	CbGeAlD
Naratriptan—MAOA—cardiac atrium—sarcoma	0.00351	0.0103	CbGeAlD
Naratriptan—MAOA—uterus—sarcoma	0.00349	0.0103	CbGeAlD
Naratriptan—MAOA—tendon—sarcoma	0.00306	0.00898	CbGeAlD
Naratriptan—MAOA—testis—sarcoma	0.00253	0.00744	CbGeAlD
Naratriptan—MAOA—liver—sarcoma	0.0024	0.00703	CbGeAlD
Naratriptan—MAOA—lymph node—sarcoma	0.00184	0.00539	CbGeAlD
Naratriptan—Skin disorder—Mitoxantrone—sarcoma	0.00115	0.00175	CcSEcCtD
Naratriptan—Cerebrovascular accident—Epirubicin—sarcoma	0.00115	0.00175	CcSEcCtD
Naratriptan—Hyperhidrosis—Mitoxantrone—sarcoma	0.00115	0.00174	CcSEcCtD
Naratriptan—Hypotension—Vincristine—sarcoma	0.00114	0.00173	CcSEcCtD
Naratriptan—Feeling abnormal—Thiotepa—sarcoma	0.00113	0.00172	CcSEcCtD
Naratriptan—Feeling abnormal—Dactinomycin—sarcoma	0.00113	0.00171	CcSEcCtD
Naratriptan—Ill-defined disorder—Etoposide—sarcoma	0.00112	0.00171	CcSEcCtD
Naratriptan—Anaemia—Etoposide—sarcoma	0.00112	0.0017	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Vincristine—sarcoma	0.00111	0.00169	CcSEcCtD
Naratriptan—Hypotension—Mitoxantrone—sarcoma	0.00111	0.00168	CcSEcCtD
Naratriptan—Migraine—Epirubicin—sarcoma	0.00111	0.00168	CcSEcCtD
Naratriptan—Paraesthesia—Vincristine—sarcoma	0.0011	0.00166	CcSEcCtD
Naratriptan—Urticaria—Thiotepa—sarcoma	0.00109	0.00166	CcSEcCtD
Naratriptan—Malaise—Etoposide—sarcoma	0.00109	0.00166	CcSEcCtD
Naratriptan—Vertigo—Etoposide—sarcoma	0.00109	0.00165	CcSEcCtD
Naratriptan—Body temperature increased—Thiotepa—sarcoma	0.00109	0.00165	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00108	0.00164	CcSEcCtD
Naratriptan—Purpura—Doxorubicin—sarcoma	0.00108	0.00164	CcSEcCtD
Naratriptan—Body temperature increased—Dactinomycin—sarcoma	0.00108	0.00164	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00108	0.00164	CcSEcCtD
Naratriptan—Paraesthesia—Mitoxantrone—sarcoma	0.00107	0.00162	CcSEcCtD
Naratriptan—Loss of consciousness—Etoposide—sarcoma	0.00106	0.00162	CcSEcCtD
Naratriptan—Cerebrovascular accident—Doxorubicin—sarcoma	0.00106	0.00162	CcSEcCtD
Naratriptan—Dyspnoea—Mitoxantrone—sarcoma	0.00106	0.00161	CcSEcCtD
Naratriptan—Cough—Etoposide—sarcoma	0.00106	0.0016	CcSEcCtD
Naratriptan—Somnolence—Mitoxantrone—sarcoma	0.00106	0.0016	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Vincristine—sarcoma	0.00105	0.0016	CcSEcCtD
Naratriptan—Fatigue—Vincristine—sarcoma	0.00105	0.0016	CcSEcCtD
Naratriptan—Convulsion—Etoposide—sarcoma	0.00105	0.00159	CcSEcCtD
Naratriptan—Dehydration—Epirubicin—sarcoma	0.00105	0.00159	CcSEcCtD
Naratriptan—Constipation—Vincristine—sarcoma	0.00104	0.00158	CcSEcCtD
Naratriptan—Pain—Vincristine—sarcoma	0.00104	0.00158	CcSEcCtD
Naratriptan—Liver function test abnormal—Epirubicin—sarcoma	0.00104	0.00158	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—sarcoma	0.00103	0.00157	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—sarcoma	0.00103	0.00156	CcSEcCtD
Naratriptan—Fatigue—Mitoxantrone—sarcoma	0.00102	0.00155	CcSEcCtD
Naratriptan—Discomfort—Etoposide—sarcoma	0.00102	0.00155	CcSEcCtD
Naratriptan—Pain—Mitoxantrone—sarcoma	0.00102	0.00154	CcSEcCtD
Naratriptan—Constipation—Mitoxantrone—sarcoma	0.00102	0.00154	CcSEcCtD
Naratriptan—Hypersensitivity—Thiotepa—sarcoma	0.00101	0.00154	CcSEcCtD
Naratriptan—Hypersensitivity—Dactinomycin—sarcoma	0.00101	0.00153	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—sarcoma	0.000998	0.00151	CcSEcCtD
Naratriptan—Confusional state—Etoposide—sarcoma	0.000997	0.00151	CcSEcCtD
Naratriptan—Anaphylactic shock—Etoposide—sarcoma	0.000989	0.0015	CcSEcCtD
Naratriptan—Asthenia—Thiotepa—sarcoma	0.000988	0.0015	CcSEcCtD
Naratriptan—Infection—Etoposide—sarcoma	0.000982	0.00149	CcSEcCtD
Naratriptan—Asthenia—Dactinomycin—sarcoma	0.00098	0.00149	CcSEcCtD
Naratriptan—Feeling abnormal—Mitoxantrone—sarcoma	0.00098	0.00149	CcSEcCtD
Naratriptan—Asthma—Epirubicin—sarcoma	0.000975	0.00148	CcSEcCtD
Naratriptan—Pruritus—Thiotepa—sarcoma	0.000974	0.00148	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—sarcoma	0.00097	0.00147	CcSEcCtD
Naratriptan—Thrombocytopenia—Etoposide—sarcoma	0.000968	0.00147	CcSEcCtD
Naratriptan—Body temperature increased—Vincristine—sarcoma	0.000965	0.00146	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—sarcoma	0.000963	0.00146	CcSEcCtD
Naratriptan—Skin disorder—Etoposide—sarcoma	0.00096	0.00146	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—sarcoma	0.000956	0.00145	CcSEcCtD
Naratriptan—Hyperhidrosis—Etoposide—sarcoma	0.000956	0.00145	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—sarcoma	0.000949	0.00144	CcSEcCtD
Naratriptan—Urticaria—Mitoxantrone—sarcoma	0.000944	0.00143	CcSEcCtD
Naratriptan—Diarrhoea—Thiotepa—sarcoma	0.000942	0.00143	CcSEcCtD
Naratriptan—Body temperature increased—Mitoxantrone—sarcoma	0.00094	0.00143	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—sarcoma	0.000937	0.00142	CcSEcCtD
Naratriptan—Diarrhoea—Dactinomycin—sarcoma	0.000935	0.00142	CcSEcCtD
Naratriptan—Hypotension—Etoposide—sarcoma	0.000924	0.0014	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—sarcoma	0.000923	0.0014	CcSEcCtD
Naratriptan—Dizziness—Thiotepa—sarcoma	0.00091	0.00138	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—sarcoma	0.000902	0.00137	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—sarcoma	0.0009	0.00137	CcSEcCtD
Naratriptan—Hypersensitivity—Vincristine—sarcoma	0.000899	0.00136	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—sarcoma	0.00089	0.00135	CcSEcCtD
Naratriptan—Paraesthesia—Etoposide—sarcoma	0.000888	0.00135	CcSEcCtD
Naratriptan—Dyspnoea—Etoposide—sarcoma	0.000881	0.00134	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—sarcoma	0.000879	0.00133	CcSEcCtD
Naratriptan—Somnolence—Etoposide—sarcoma	0.000879	0.00133	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—sarcoma	0.000878	0.00133	CcSEcCtD
Naratriptan—Hypersensitivity—Mitoxantrone—sarcoma	0.000876	0.00133	CcSEcCtD
Naratriptan—Asthenia—Vincristine—sarcoma	0.000876	0.00133	CcSEcCtD
Naratriptan—Vomiting—Thiotepa—sarcoma	0.000875	0.00133	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—sarcoma	0.000874	0.00133	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—sarcoma	0.000869	0.00132	CcSEcCtD
Naratriptan—Vomiting—Dactinomycin—sarcoma	0.000869	0.00132	CcSEcCtD
Naratriptan—Rash—Thiotepa—sarcoma	0.000868	0.00132	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—sarcoma	0.000867	0.00132	CcSEcCtD
Naratriptan—Dermatitis—Thiotepa—sarcoma	0.000867	0.00132	CcSEcCtD
Naratriptan—Headache—Thiotepa—sarcoma	0.000862	0.00131	CcSEcCtD
Naratriptan—Rash—Dactinomycin—sarcoma	0.000861	0.00131	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Etoposide—sarcoma	0.000854	0.00129	CcSEcCtD
Naratriptan—Asthenia—Mitoxantrone—sarcoma	0.000853	0.00129	CcSEcCtD
Naratriptan—Fatigue—Etoposide—sarcoma	0.000852	0.00129	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—sarcoma	0.000852	0.00129	CcSEcCtD
Naratriptan—Pain—Etoposide—sarcoma	0.000845	0.00128	CcSEcCtD
Naratriptan—Constipation—Etoposide—sarcoma	0.000845	0.00128	CcSEcCtD
Naratriptan—Diarrhoea—Vincristine—sarcoma	0.000835	0.00127	CcSEcCtD
Naratriptan—Sweating—Epirubicin—sarcoma	0.000833	0.00126	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—sarcoma	0.000833	0.00126	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—sarcoma	0.000823	0.00125	CcSEcCtD
Naratriptan—Nausea—Thiotepa—sarcoma	0.000818	0.00124	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—sarcoma	0.000815	0.00124	CcSEcCtD
Naratriptan—Feeling abnormal—Etoposide—sarcoma	0.000815	0.00124	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—sarcoma	0.000813	0.00123	CcSEcCtD
Naratriptan—Diarrhoea—Mitoxantrone—sarcoma	0.000813	0.00123	CcSEcCtD
Naratriptan—Nausea—Dactinomycin—sarcoma	0.000811	0.00123	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—sarcoma	0.000809	0.00123	CcSEcCtD
Naratriptan—Dizziness—Vincristine—sarcoma	0.000807	0.00122	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—sarcoma	0.000804	0.00122	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—sarcoma	0.000794	0.0012	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—sarcoma	0.000788	0.0012	CcSEcCtD
Naratriptan—Urticaria—Etoposide—sarcoma	0.000785	0.00119	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—sarcoma	0.000784	0.00119	CcSEcCtD
Naratriptan—Body temperature increased—Etoposide—sarcoma	0.000782	0.00119	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—sarcoma	0.00078	0.00118	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—sarcoma	0.000776	0.00118	CcSEcCtD
Naratriptan—Vomiting—Vincristine—sarcoma	0.000776	0.00118	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—sarcoma	0.000771	0.00117	CcSEcCtD
Naratriptan—Rash—Vincristine—sarcoma	0.00077	0.00117	CcSEcCtD
Naratriptan—Dermatitis—Vincristine—sarcoma	0.000769	0.00117	CcSEcCtD
Naratriptan—Headache—Vincristine—sarcoma	0.000765	0.00116	CcSEcCtD
Naratriptan—Vomiting—Mitoxantrone—sarcoma	0.000756	0.00115	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—sarcoma	0.000754	0.00114	CcSEcCtD
Naratriptan—Rash—Mitoxantrone—sarcoma	0.000749	0.00114	CcSEcCtD
Naratriptan—Dermatitis—Mitoxantrone—sarcoma	0.000749	0.00114	CcSEcCtD
Naratriptan—Headache—Mitoxantrone—sarcoma	0.000745	0.00113	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—sarcoma	0.000735	0.00111	CcSEcCtD
Naratriptan—Hypersensitivity—Etoposide—sarcoma	0.000728	0.00111	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—sarcoma	0.000727	0.0011	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—sarcoma	0.000725	0.0011	CcSEcCtD
Naratriptan—Nausea—Vincristine—sarcoma	0.000725	0.0011	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—sarcoma	0.000724	0.0011	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—sarcoma	0.000722	0.0011	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—sarcoma	0.000718	0.00109	CcSEcCtD
Naratriptan—Asthenia—Etoposide—sarcoma	0.000709	0.00108	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—sarcoma	0.000708	0.00107	CcSEcCtD
Naratriptan—Nausea—Mitoxantrone—sarcoma	0.000706	0.00107	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—sarcoma	0.000705	0.00107	CcSEcCtD
Naratriptan—Chills—Epirubicin—sarcoma	0.0007	0.00106	CcSEcCtD
Naratriptan—Pruritus—Etoposide—sarcoma	0.0007	0.00106	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—sarcoma	0.000697	0.00106	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—sarcoma	0.000689	0.00105	CcSEcCtD
Naratriptan—Erythema—Epirubicin—sarcoma	0.000679	0.00103	CcSEcCtD
Naratriptan—Diarrhoea—Etoposide—sarcoma	0.000676	0.00103	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—sarcoma	0.000673	0.00102	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—sarcoma	0.00067	0.00102	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—sarcoma	0.000655	0.000993	CcSEcCtD
Naratriptan—Dizziness—Etoposide—sarcoma	0.000654	0.000992	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—sarcoma	0.000653	0.00099	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—sarcoma	0.000652	0.000989	CcSEcCtD
Naratriptan—Chills—Doxorubicin—sarcoma	0.000648	0.000983	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—sarcoma	0.000645	0.000978	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—sarcoma	0.00064	0.000971	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—sarcoma	0.000638	0.000968	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—sarcoma	0.00063	0.000956	CcSEcCtD
Naratriptan—Vomiting—Etoposide—sarcoma	0.000629	0.000954	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—sarcoma	0.000628	0.000953	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—sarcoma	0.000628	0.000952	CcSEcCtD
Naratriptan—Agitation—Epirubicin—sarcoma	0.000624	0.000947	CcSEcCtD
Naratriptan—Rash—Etoposide—sarcoma	0.000623	0.000946	CcSEcCtD
Naratriptan—Dermatitis—Etoposide—sarcoma	0.000623	0.000945	CcSEcCtD
Naratriptan—Headache—Etoposide—sarcoma	0.000619	0.00094	CcSEcCtD
Naratriptan—Malaise—Epirubicin—sarcoma	0.000612	0.000929	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—sarcoma	0.00061	0.000926	CcSEcCtD
Naratriptan—Syncope—Epirubicin—sarcoma	0.000609	0.000924	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—sarcoma	0.000604	0.000916	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—sarcoma	0.0006	0.00091	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—sarcoma	0.000597	0.000905	CcSEcCtD
Naratriptan—Cough—Epirubicin—sarcoma	0.000593	0.000899	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—sarcoma	0.000592	0.000898	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—sarcoma	0.000588	0.000893	CcSEcCtD
Naratriptan—Nausea—Etoposide—sarcoma	0.000587	0.000891	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—sarcoma	0.000583	0.000884	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—sarcoma	0.000581	0.000881	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—sarcoma	0.000578	0.000877	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—sarcoma	0.000578	0.000877	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—sarcoma	0.000577	0.000876	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—sarcoma	0.000576	0.000874	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—sarcoma	0.000571	0.000867	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—sarcoma	0.000567	0.00086	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—sarcoma	0.000565	0.000858	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—sarcoma	0.000565	0.000856	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—sarcoma	0.000563	0.000855	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—sarcoma	0.000559	0.000848	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—sarcoma	0.000555	0.000842	CcSEcCtD
Naratriptan—Oedema—Epirubicin—sarcoma	0.000554	0.000841	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—sarcoma	0.000554	0.000841	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—sarcoma	0.000552	0.000838	CcSEcCtD
Naratriptan—Infection—Epirubicin—sarcoma	0.000551	0.000835	CcSEcCtD
Naratriptan—Cough—Doxorubicin—sarcoma	0.000548	0.000832	CcSEcCtD
Naratriptan—Shock—Epirubicin—sarcoma	0.000545	0.000827	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—sarcoma	0.000544	0.000826	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—sarcoma	0.000544	0.000825	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—sarcoma	0.000543	0.000823	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—sarcoma	0.000538	0.000817	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—sarcoma	0.000536	0.000813	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—sarcoma	0.000535	0.000812	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—sarcoma	0.000535	0.000812	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—sarcoma	0.000533	0.000809	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—sarcoma	0.000529	0.000802	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—sarcoma	0.000523	0.000794	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—sarcoma	0.000518	0.000786	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—sarcoma	0.000517	0.000784	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—sarcoma	0.000513	0.000778	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—sarcoma	0.000513	0.000778	CcSEcCtD
Naratriptan—Infection—Doxorubicin—sarcoma	0.000509	0.000773	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000505	0.000766	CcSEcCtD
Naratriptan—Shock—Doxorubicin—sarcoma	0.000505	0.000765	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—sarcoma	0.000503	0.000763	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—sarcoma	0.000502	0.000762	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—sarcoma	0.000498	0.000756	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—sarcoma	0.000498	0.000755	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—sarcoma	0.000496	0.000752	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—sarcoma	0.000494	0.00075	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—sarcoma	0.000493	0.000747	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—sarcoma	0.000479	0.000727	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—sarcoma	0.000478	0.000726	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—sarcoma	0.000478	0.000725	CcSEcCtD
Naratriptan—Constipation—Epirubicin—sarcoma	0.000474	0.000719	CcSEcCtD
Naratriptan—Pain—Epirubicin—sarcoma	0.000474	0.000719	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000467	0.000709	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—sarcoma	0.00046	0.000699	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—sarcoma	0.000457	0.000694	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—sarcoma	0.000457	0.000693	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—sarcoma	0.000456	0.000692	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000443	0.000672	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—sarcoma	0.000442	0.000671	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—sarcoma	0.00044	0.000668	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—sarcoma	0.000439	0.000665	CcSEcCtD
Naratriptan—Pain—Doxorubicin—sarcoma	0.000439	0.000665	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—sarcoma	0.000438	0.000665	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—sarcoma	0.000423	0.000641	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—sarcoma	0.000408	0.000619	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—sarcoma	0.000407	0.000618	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—sarcoma	0.000405	0.000615	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—sarcoma	0.000398	0.000603	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—sarcoma	0.000392	0.000595	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—sarcoma	0.000379	0.000575	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—sarcoma	0.000378	0.000573	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—sarcoma	0.000368	0.000558	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—sarcoma	0.000366	0.000556	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—sarcoma	0.000363	0.00055	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—sarcoma	0.000352	0.000535	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—sarcoma	0.000351	0.000532	CcSEcCtD
Naratriptan—Rash—Epirubicin—sarcoma	0.000349	0.00053	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—sarcoma	0.000349	0.00053	CcSEcCtD
Naratriptan—Headache—Epirubicin—sarcoma	0.000347	0.000527	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—sarcoma	0.000339	0.000514	CcSEcCtD
Naratriptan—Nausea—Epirubicin—sarcoma	0.000329	0.000499	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—sarcoma	0.000326	0.000495	CcSEcCtD
Naratriptan—Rash—Doxorubicin—sarcoma	0.000323	0.000491	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—sarcoma	0.000323	0.00049	CcSEcCtD
Naratriptan—Headache—Doxorubicin—sarcoma	0.000321	0.000487	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—sarcoma	0.000305	0.000462	CcSEcCtD
